- Home
- CDTX vs NCA Comparison
CDTX vs NCA Comparison
Compare CDTX & NCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- NCA
- Stock Information
- Founded
- CDTX 2012
- NCA 1987
- Country
- CDTX United States
- NCA United States
- Employees
- CDTX N/A
- NCA N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- NCA Investment Managers
- Sector
- CDTX Health Care
- NCA Finance
- Exchange
- CDTX Nasdaq
- NCA Nasdaq
- Market Cap
- CDTX 333.3M
- NCA 278.1M
- IPO Year
- CDTX 2015
- NCA N/A
- Fundamental
- Price
- CDTX $21.02
- NCA $8.45
- Analyst Decision
- CDTX Strong Buy
- NCA
- Analyst Count
- CDTX 9
- NCA 0
- Target Price
- CDTX $41.29
- NCA N/A
- AVG Volume (30 Days)
- CDTX 202.2K
- NCA 59.6K
- Earning Date
- CDTX 08-12-2025
- NCA 01-01-0001
- Dividend Yield
- CDTX N/A
- NCA 3.92%
- EPS Growth
- CDTX N/A
- NCA N/A
- EPS
- CDTX N/A
- NCA N/A
- Revenue
- CDTX $302,000.00
- NCA N/A
- Revenue This Year
- CDTX N/A
- NCA N/A
- Revenue Next Year
- CDTX N/A
- NCA N/A
- P/E Ratio
- CDTX N/A
- NCA N/A
- Revenue Growth
- CDTX N/A
- NCA N/A
- 52 Week Low
- CDTX $10.14
- NCA $7.77
- 52 Week High
- CDTX $28.42
- NCA $9.12
- Technical
- Relative Strength Index (RSI)
- CDTX 39.72
- NCA 49.29
- Support Level
- CDTX $21.14
- NCA $8.39
- Resistance Level
- CDTX $22.60
- NCA $8.56
- Average True Range (ATR)
- CDTX 1.54
- NCA 0.09
- MACD
- CDTX -0.51
- NCA 0.00
- Stochastic Oscillator
- CDTX 12.57
- NCA 41.30
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About NCA Nuveen California Municipal Value Fund
Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. Its primary objective is to provide current income exempt from regular federal and California income taxes. The fund's secondary objective is to enhance portfolio value relative to the California municipal bond market by investing in tax-exempt California municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.